These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 31181394

  • 1. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant.
    Mei T, Kim A, Vong LB, Marushima A, Puentes S, Matsumaru Y, Matsumura A, Nagasaki Y.
    Biomaterials; 2019 Sep; 215():119209. PubMed ID: 31181394
    [Abstract] [Full Text] [Related]

  • 2. Fibrinolytic tissue plasminogen activator installed redox-active nanoparticles (t-PA@iRNP) for cancer therapy.
    Mei T, Shashni B, Maeda H, Nagasaki Y.
    Biomaterials; 2020 Nov; 259():120290. PubMed ID: 32829147
    [Abstract] [Full Text] [Related]

  • 3. Neurovascular Unit Protection From Cerebral Ischemia-Reperfusion Injury by Radical-Containing Nanoparticles in Mice.
    Hosoo H, Marushima A, Nagasaki Y, Hirayama A, Ito H, Puentes S, Mujagic A, Tsurushima H, Tsuruta W, Suzuki K, Matsui H, Matsumaru Y, Yamamoto T, Matsumura A.
    Stroke; 2017 Aug; 48(8):2238-2247. PubMed ID: 28655813
    [Abstract] [Full Text] [Related]

  • 4. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion.
    Miyazaki T, Kimura Y, Ohata H, Hashimoto T, Shibata K, Hasumi K, Honda K.
    Stroke; 2011 Apr; 42(4):1097-104. PubMed ID: 21350203
    [Abstract] [Full Text] [Related]

  • 5. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY, Lee MY, Chen HY, Kuo YL, Lin SC, Wu TS, Lee EJ.
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [Abstract] [Full Text] [Related]

  • 6. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M, Beray-Berthat V, Coqueran B, Plotkine M, Marchand-Leroux C, Margaill I.
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [Abstract] [Full Text] [Related]

  • 7. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain.
    Petro M, Jaffer H, Yang J, Kabu S, Morris VB, Labhasetwar V.
    Biomaterials; 2016 Mar; 81():169-180. PubMed ID: 26735970
    [Abstract] [Full Text] [Related]

  • 8. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles.
    Yoshitomi T, Hirayama A, Nagasaki Y.
    Biomaterials; 2011 Nov; 32(31):8021-8. PubMed ID: 21816462
    [Abstract] [Full Text] [Related]

  • 9. Oxidative stress after thrombolysis-induced reperfusion in human stroke.
    Domínguez C, Delgado P, Vilches A, Martín-Gallán P, Ribó M, Santamarina E, Molina C, Corbeto N, Rodríguez-Sureda V, Rosell A, Alvarez-Sabín J, Montaner J.
    Stroke; 2010 Apr; 41(4):653-60. PubMed ID: 20185784
    [Abstract] [Full Text] [Related]

  • 10. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J, Qi Z, Liu W, Wang P, Shi W, Dong W, Ji X, Luo Y, Liu KJ.
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy of normobaric oxygen with hypothermia or ethanol modulates pyruvate dehydrogenase complex in thromboembolic cerebral ischemia.
    Cai L, Thibodeau A, Peng C, Ji X, Rastogi R, Xin R, Singh S, Geng X, Rafols JA, Ding Y.
    J Neurosci Res; 2016 Aug; 94(8):749-58. PubMed ID: 27027410
    [Abstract] [Full Text] [Related]

  • 12. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
    Yoshitomi T, Nagasaki Y.
    Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
    [Abstract] [Full Text] [Related]

  • 13. Recombinant Human Heavy Chain Ferritin Nanoparticles Serve as ROS Scavengers for the Treatment of Ischemic Stroke.
    Qi M, Cheng Y, Liu K, Cai J, Liu T, Wu X, Tang H, Huang H, Chen Q, Zhou X.
    Int J Nanomedicine; 2024 Aug; 19():2285-2299. PubMed ID: 38482520
    [Abstract] [Full Text] [Related]

  • 14. Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.
    Takamiya M, Miyamoto Y, Yamashita T, Deguchi K, Ohta Y, Abe K.
    Neuroscience; 2012 Sep 27; 221():47-55. PubMed ID: 22766232
    [Abstract] [Full Text] [Related]

  • 15. t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke.
    Draxler DF, Lee F, Ho H, Keragala CB, Medcalf RL, Niego B.
    Front Immunol; 2019 Sep 27; 10():591. PubMed ID: 30972077
    [Abstract] [Full Text] [Related]

  • 16. Endogenous tissue plasminogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains.
    Tang J, Li YJ, Li Q, Mu J, Yang DY, Xie P.
    Neurol Res; 2010 Jun 27; 32(5):541-6. PubMed ID: 19309545
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
    Kollmar R, Henninger N, Bardutzky J, Schellinger PD, Schäbitz WR, Schwab S.
    Exp Neurol; 2004 Nov 27; 190(1):204-12. PubMed ID: 15473993
    [Abstract] [Full Text] [Related]

  • 18. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.
    Chen H, Guan B, Chen X, Chen X, Li C, Qiu J, Yang D, Liu KJ, Qi S, Shen J.
    Transl Stroke Res; 2018 Oct 27; 9(5):515-529. PubMed ID: 29275501
    [Abstract] [Full Text] [Related]

  • 19. Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.
    Karatas H, Eun Jung J, Lo EH, van Leyen K.
    Brain Res; 2018 Jan 01; 1678():123-128. PubMed ID: 29079502
    [Abstract] [Full Text] [Related]

  • 20. Post-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin can reduce ischemia reperfusion injury.
    Shimbo D, Abumiya T, Shichinohe H, Nakayama N, Kazumata K, Houkin K.
    Brain Res; 2014 Mar 20; 1554():59-66. PubMed ID: 24486612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.